$RARX Ra Pharmaceuticals, Inc. Insider Trading Week 13/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ra Pharmaceuticals, Inc. in week 13/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Sell | D | 0.00 | 6,135,234 | 0 | 0 | 6.1 M to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Mathers Edward T | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Mathers Edward T | Director | Option Exercise | D | 9.90 | 15,000 | 148,500 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Mathers Edward T | Director | Option Exercise | D | 22.37 | 15,000 | 335,550 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 0.00 | 20,833 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 21.00 | 311,000 | 6,531,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 7.33 | 125,000 | 916,250 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 16.64 | 225,000 | 3,744,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 5.60 | 164,285 | 919,996 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 2.87 | 241,460 | 692,990 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 2.87 | 139,371 | 399,995 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Sell | D | 48.00 | 234,707 | 11,265,936 | 0 | 234.7 K to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 0.00 | 10,416 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 21.00 | 133,000 | 2,793,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 7.33 | 62,500 | 458,125 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 16.64 | 112,500 | 1,872,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 5.60 | 28,571 | 159,998 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 2.87 | 92,283 | 264,852 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 2.87 | 115,572 | 331,692 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Sell | D | 48.00 | 15,622 | 749,856 | 0 | 15.6 K to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Option Exercise | D | 0.00 | 4,375 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Option Exercise | D | 21.00 | 107,000 | 2,247,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Option Exercise | D | 7.33 | 26,250 | 192,413 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Option Exercise | D | 16.64 | 60,000 | 998,400 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Option Exercise | D | 5.60 | 31,428 | 175,997 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Option Exercise | D | 2.87 | 30,000 | 86,100 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Option Exercise | D | 2.87 | 14,285 | 40,998 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Option Exercise | D | 0.84 | 2,857 | 2,400 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Ricardo Alonso | See Remarks | Sell | D | 48.00 | 2,973 | 142,704 | 0 | 3 K to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 0.00 | 9,166 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 21.00 | 107,000 | 2,247,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 7.33 | 55,000 | 403,150 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 16.64 | 67,500 | 1,123,200 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 5.60 | 25,000 | 140,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 2.87 | 26,422 | 75,831 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 2.87 | 46,434 | 133,266 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | D | 48.00 | 12,595 | 604,560 | 0 | 12.6 K to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | D | 0.00 | 10,416 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | D | 21.00 | 133,000 | 2,793,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | D | 7.33 | 62,500 | 458,125 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | D | 16.64 | 90,000 | 1,497,600 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | D | 5.60 | 73,654 | 412,462 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | D | 5.60 | 11,110 | 62,216 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Sell | D | 48.00 | 14,492 | 695,616 | 0 | 14.5 K to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Cumbo Alexander | Director | Option Exercise | D | 12.99 | 25,000 | 324,750 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Cumbo Alexander | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | PEARSON TIMOTHY R | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | PEARSON TIMOTHY R | Director | Option Exercise | D | 9.90 | 15,000 | 148,500 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | PEARSON TIMOTHY R | Director | Option Exercise | D | 22.37 | 15,000 | 335,550 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | PEARSON TIMOTHY R | Director | Option Exercise | D | 2.87 | 22,857 | 65,600 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | D | 0.00 | 30,658 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | D | 21.00 | 107,000 | 2,247,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | D | 6.20 | 190,000 | 1,178,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Sell | D | 48.00 | 10,823 | 519,504 | 0 | 10.8 K to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 9.90 | 15,000 | 148,500 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 22.37 | 15,000 | 335,550 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Sell | D | 48.00 | 4,858,260 | 233,196,480 | 0 | 4.9 M to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Heft Robert | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Heft Robert | Director | Option Exercise | D | 9.90 | 15,000 | 148,500 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Heft Robert | Director | Option Exercise | D | 22.37 | 15,000 | 335,550 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Heft Robert | Director | Option Exercise | D | 2.87 | 22,857 | 65,600 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | RA CAPITAL MANAGEMENT, L.P. | Director | Sell | D | 48.00 | 4,858,260 | 233,196,480 | 0 | 4.9 M to 0 (-100.00 %) |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Brennan Aoife | Director | Option Exercise | D | 16.36 | 25,000 | 409,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Brennan Aoife | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 |